Prelude Capital Management’s ProShares Ultra VIX Short-Term Futures ETF UVXY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,289
Closed -$1.22M 1570
2025
Q3
$1.22M Buy
23,289
+12,060
+107% +$839K 0.09% 270
2025
Q2
$1.05M Buy
11,229
+1,828
+19% +$242K 0.1% 247
2025
Q1
$1.1M Buy
+9,401
New +$972K 0.08% 289
2023
Q4
Sell
-420
Closed -$170K 1362
2023
Q3
$170K Sell
420
-261
-38% -$109K 0.01% 938
2023
Q2
$315K Buy
681
+523
+331% +$420K 0.02% 619
2023
Q1
$184K Sell
158
-16
-9% -$21.4K 0.01% 879
2022
Q4
$299K Buy
+174
New +$408K 0.02% 794
2020
Q4
Hold
0
2029
2020
Q3
Hold
0
1684
2020
Q2
Hold
0
1579
2016
Q2
Hold
0
-$114K 1755
2016
Q1
Hold
0
717
2015
Q4
Hold
0
-$28K 1702
2015
Q3
Hold
0
1189
2014
Q4
Hold
0
-$111K 2166
2014
Q3
Hold
0
1044
2014
Q2
Hold
0
1098
2014
Q1
Hold
0
208
2013
Q4
Hold
0
781

Other funds holding UVXY

Prelude Capital Management's UVXY Position: Q4 2025 in Review

Prelude Capital Management sold out of ProShares Ultra VIX Short-Term Futures ETF (UVXY) in Q4 2025, closing a stake of 23,289 shares — an estimated $1.22M sold.

Prelude Capital Management first reported a position in UVXY in Q4 2022 and held it in 7 quarters. The position peaked at $1.22M in Q3 2025. 32 funds tracked by Wall St. Rank hold UVXY as of Q4 2025.

  • Prelude Capital Management reported no remaining ProShares Ultra VIX Short-Term Futures ETF position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 23,289 ProShares Ultra VIX Short-Term Futures ETF shares in Q4 2025, an estimated $1.22M.
  • Prelude Capital Management first reported a position in ProShares Ultra VIX Short-Term Futures ETF in Q4 2022 and held it in 7 quarters.
  • Prelude Capital Management's ProShares Ultra VIX Short-Term Futures ETF position peaked at $1.22M in Q3 2025.
  • 32 funds tracked by Wall St. Rank held ProShares Ultra VIX Short-Term Futures ETF as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.